| Q44630336 | 5-HT induces duodenal mucosal bicarbonate secretion via cAMP- and Ca2+-dependent signaling pathways and 5-HT4 receptors in mice |
| Q35042832 | 5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle |
| Q39294002 | 5-HT3 receptors: A potential therapeutic target for epilepsy |
| Q50298318 | 5-HT4, 6 and 7 receptors can bind serotonin |
| Q33677071 | 7TM receptors: the splicing on the cake |
| Q28142963 | A review of central 5-HT receptors and their function |
| Q28377434 | Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine |
| Q37258385 | Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. |
| Q53435085 | Association of 5-hydroxytryptamine (serotonin) receptor 4 (5-HTR4) gene polymorphisms with asthma. |
| Q42966841 | Cardiac overexpression of the human 5-HT4 receptor in mice. |
| Q35044960 | Characterization of human 5-HT4(d) receptor desensitization in CHO cells |
| Q34982112 | Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity |
| Q34105746 | Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants |
| Q42460996 | Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i). |
| Q33292564 | Constitutive dimerization of human serotonin 5-HT4 receptors in living cells |
| Q44914306 | Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4 agonist tegaserod |
| Q35834548 | Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human Colon |
| Q28344302 | Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling |
| Q46613363 | Expression and function of 5-HT4 receptors in the mouse enteric nervous system |
| Q39773634 | Four exons of the serotonin receptor 4 gene are associated with multiple distant branch points |
| Q45057731 | Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure |
| Q40485635 | Functional studies of the 5'-untranslated region of human 5-HT4 receptor mRNA. |
| Q37420451 | Human 5-HT(4) and 5-HT(7) receptor splice variants: are they important? |
| Q85888495 | Human 5-HT₄receptor stimulation in atria of transgenic mice |
| Q38308591 | Identification and characterization of a truncated variant of the 5-hydroxytryptamine(2A) receptor produced by alternative splicing |
| Q37563446 | Identification and functional characterisation of 5-HT4 receptor in sea cucumber Apostichopus japonicus (Selenka). |
| Q35840225 | Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development |
| Q34902609 | Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene |
| Q24675224 | Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines |
| Q42474921 | Modulation of spontaneous firing in rat subthalamic neurons by 5-HT receptor subtypes. |
| Q28206145 | Molecular, pharmacological and functional diversity of 5-HT receptors |
| Q28210479 | Multiplicity of mechanisms of serotonin receptor signal transduction |
| Q42501591 | Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function |
| Q35047707 | New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket |
| Q37735172 | New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders |
| Q34648658 | Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity |
| Q35566501 | Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle |
| Q24674531 | Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells |
| Q34728081 | Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome |
| Q46252240 | Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium |
| Q35098633 | Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development |
| Q37800812 | Presynaptic control of serotonin on striatal dopamine function |
| Q33951364 | Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. |
| Q42464964 | Serotonin 5-HT4 receptors and forebrain cholinergic system: receptor expression in identified cell populations |
| Q42475635 | Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions |
| Q36647024 | Serotonin receptor signaling and regulation via β-arrestins |
| Q28369138 | Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant |
| Q63437454 | Study of serotonin interactions with brush border membrane of rabbit jejunum enterocytes |
| Q34166903 | Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders |
| Q42132345 | The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor. |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q35025872 | The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties |
| Q40045695 | The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome |
| Q24673213 | The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects |
| Q43754809 | The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. |
| Q34770217 | The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity |